Neurophysiological Basis of Deep Brain Stimulation and Botulinum Neurotoxin Injection for Treating Oromandibular Dystonia
- PMID: 36356002
- PMCID: PMC9694803
- DOI: 10.3390/toxins14110751
Neurophysiological Basis of Deep Brain Stimulation and Botulinum Neurotoxin Injection for Treating Oromandibular Dystonia
Abstract
Oromandibular dystonia (OMD) induces severe motor impairments, such as masticatory disturbances, dysphagia, and dysarthria, resulting in a serious decline in quality of life. Non-invasive brain-imaging techniques such as electroencephalography (EEG) and magnetoencephalography (MEG) are powerful approaches that can elucidate human cortical activity with high temporal resolution. Previous studies with EEG and MEG have revealed that movements in the stomatognathic system are regulated by the bilateral central cortex. Recently, in addition to the standard therapy of botulinum neurotoxin (BoNT) injection into the affected muscles, bilateral deep brain stimulation (DBS) has been applied for the treatment of OMD. However, some patients' OMD symptoms do not improve sufficiently after DBS, and they require additional BoNT therapy. In this review, we provide an overview of the unique central spatiotemporal processing mechanisms in these regions in the bilateral cortex using EEG and MEG, as they relate to the sensorimotor functions of the stomatognathic system. Increased knowledge regarding the neurophysiological underpinnings of the stomatognathic system will improve our understanding of OMD and other movement disorders, as well as aid the development of potential novel approaches such as combination treatment with BoNT injection and DBS or non-invasive cortical current stimulation therapies.
Keywords: botulinum neurotoxin; deep brain stimulation; electroencephalography; globus pallidus; magnetoencephalography; motor function; oromandibular dystonia; sensorimotor function; stomatognathic function.
Conflict of interest statement
The authors declare no conflict of interest.
Figures


Similar articles
-
Botulinum Toxin and Deep Brain Stimulation in Dystonia.Toxins (Basel). 2024 Jun 20;16(6):282. doi: 10.3390/toxins16060282. Toxins (Basel). 2024. PMID: 38922176 Free PMC article.
-
Effects of Botulinum Toxin Therapy on Health-Related Quality of Life Evaluated by the Oromandibular Dystonia Rating Scale.Toxins (Basel). 2022 Sep 22;14(10):656. doi: 10.3390/toxins14100656. Toxins (Basel). 2022. PMID: 36287925 Free PMC article.
-
Botulinum neurotoxin a therapy efficacy and safety for oromandibular dystonia: a meta-analysis.J Neural Transm (Vienna). 2019 Feb;126(2):141-148. doi: 10.1007/s00702-018-1960-7. Epub 2019 Jan 2. J Neural Transm (Vienna). 2019. PMID: 30604200
-
Botulinum Toxin Therapy for Oromandibular Dystonia and Other Movement Disorders in the Stomatognathic System.Toxins (Basel). 2022 Apr 14;14(4):282. doi: 10.3390/toxins14040282. Toxins (Basel). 2022. PMID: 35448891 Free PMC article. Review.
-
Deep Brain Stimulation for Focal or Segmental Craniocervical Dystonia in Patients Who Have Failed Botulinum Neurotoxin Therapy-A Narrative Review of the Literature.Toxins (Basel). 2023 Oct 9;15(10):606. doi: 10.3390/toxins15100606. Toxins (Basel). 2023. PMID: 37888637 Free PMC article. Review.
Cited by
-
Treatment with OnabotulinumtoxinA for Oromandibular Dystonia: A Systematic Review and Meta-Analysis.Toxins (Basel). 2024 Dec 16;16(12):546. doi: 10.3390/toxins16120546. Toxins (Basel). 2024. PMID: 39728804 Free PMC article.
-
Botulinum Toxin and Deep Brain Stimulation in Dystonia.Toxins (Basel). 2024 Jun 20;16(6):282. doi: 10.3390/toxins16060282. Toxins (Basel). 2024. PMID: 38922176 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical